Skip to main content
Journal cover image

PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.

Publication ,  Journal Article
Peters, PN; Pierson, WE; Chen, L-M; Westphalen, AC; Chapman, JS; Hsu, I-C
Published in: Abdominal radiology (New York)
January 2021

We aimed to examine utilization patterns of positron emission tomography scans (PET or PET/CT) beyond 6 months after cervical cancer treatment. We investigated survival outcomes of asymptomatic patients with PET-detected recurrence.We performed a retrospective review of 283 patients with stage IA-IVA cervical cancer treated with primary chemoradiation. The 107 patients (37.8%) with recurrence were categorized as "asymptomatic PET-detected recurrence" (n = 23) or "standard detection" (n = 84) and we compared clinical characteristics and outcomes using multivariate logistic regression analysis.Late post-treatment PET (≥ 6 months after treatment) was performed in 35.3% (n = 100). Indications for late post-treatment PET included restaging in setting of known recurrence (23.6%), follow up of prior ambiguous imaging findings (9.7%), and new symptoms or exam findings (6.7%). However, late post-treatment PET was most commonly performed outside of current imaging guidelines, in asymptomatic patients without suspicion for recurrence (60.0%), presumably for surveillance. The median time to recurrence was 12.1 months (IQR 7.3-26.6). 23 patients (21.5%) had recurrence detected late post-treatment PET while asymptomatic (n = 23/107). Patients with asymptomatic PET-detected recurrence had improved survival by 26.3 months compared to the standard detection cohort (50.3 vs 24.0 months, p = 0.0015). On multivariate analysis, predictors of survival after recurrence were presence of distant metastases at diagnosis (p = 0.010) and asymptomatic PET-detected recurrence (p = 0.039).PET imaging in asymptomatic patients beyond 6 months after treatment may have clinical benefit and warrants further study. Detection of recurrence by PET in asymptomatic patients ≥ 6 months after chemoradiation was associated with prolonged survival by more than   2 years.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Abdominal radiology (New York)

DOI

EISSN

2366-0058

ISSN

2366-004X

Publication Date

January 2021

Volume

46

Issue

1

Start / End Page

341 / 350

Related Subject Headings

  • Uterine Cervical Neoplasms
  • Retrospective Studies
  • Positron-Emission Tomography
  • Positron Emission Tomography Computed Tomography
  • Neoplasm Recurrence, Local
  • Humans
  • Fluorodeoxyglucose F18
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, P. N., Pierson, W. E., Chen, L.-M., Westphalen, A. C., Chapman, J. S., & Hsu, I.-C. (2021). PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer. Abdominal Radiology (New York), 46(1), 341–350. https://doi.org/10.1007/s00261-020-02633-0
Peters, Pamela N., William E. Pierson, Lee-May Chen, Antonio C. Westphalen, Jocelyn S. Chapman, and I-Chow Hsu. “PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.Abdominal Radiology (New York) 46, no. 1 (January 2021): 341–50. https://doi.org/10.1007/s00261-020-02633-0.
Peters PN, Pierson WE, Chen L-M, Westphalen AC, Chapman JS, Hsu I-C. PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer. Abdominal radiology (New York). 2021 Jan;46(1):341–50.
Peters, Pamela N., et al. “PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.Abdominal Radiology (New York), vol. 46, no. 1, Jan. 2021, pp. 341–50. Epmc, doi:10.1007/s00261-020-02633-0.
Peters PN, Pierson WE, Chen L-M, Westphalen AC, Chapman JS, Hsu I-C. PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer. Abdominal radiology (New York). 2021 Jan;46(1):341–350.
Journal cover image

Published In

Abdominal radiology (New York)

DOI

EISSN

2366-0058

ISSN

2366-004X

Publication Date

January 2021

Volume

46

Issue

1

Start / End Page

341 / 350

Related Subject Headings

  • Uterine Cervical Neoplasms
  • Retrospective Studies
  • Positron-Emission Tomography
  • Positron Emission Tomography Computed Tomography
  • Neoplasm Recurrence, Local
  • Humans
  • Fluorodeoxyglucose F18
  • Female